MARK HAROLD PETRY
- Type
- Physician · Allopathic & Osteopathic Physicians / Family Medicine
- Where
- SANDSTONE, MN
- NPI
- 1487668034
- Received
- $1,013 in 66 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 11 | $181 |
| 2024 | General payment | 12 | $198 |
| 2023 | General payment | 9 | $143 |
| 2022 | General payment | 8 | $110 |
| 2021 | General payment | 18 | $270 |
| 2020 | General payment | 2 | $24 |
| 2019 | General payment | 6 | $85 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 66 | $1,013 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-16 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $13 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-02 | Viatris Specialty LLC | $18 | Food and Beverage | In-kind items and services | YUPELRI Drug, Anticholinergics, Inhaled | 2025 | |
| 2025-07-30 | Xeris Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | KEVEYIS Drug, Carbonic anhydrase inhibitor | 2025 | |
| 2025-07-16 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-22 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | BREZTRI Drug, Respiratory | 2025 | |
| 2025-05-07 | Xeris Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | KEVEYIS Drug, Carbonic anhydrase inhibitor | 2025 | |
| 2025-04-02 | Xeris Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | KEVEYIS Drug, Carbonic anhydrase inhibitor | 2025 | |
| 2025-03-14 | Xeris Pharmaceuticals, Inc. | $18 | Food and Beverage | In-kind items and services | KEVEYIS Drug, Carbonic anhydrase inhibitor | 2025 | |
| 2025-03-06 | Aimmune Therapeutics, Inc. | $16 | Food and Beverage | In-kind items and services | ZENPEP Drug, ENDOCRINE PANCREATIC INSUFFICIENCY | 2025 | |
| 2025-02-28 | Novo Nordisk Inc | $13 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-01-22 | Phathom Pharmaceuticals, Inc. | $7 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2024-12-24 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-10-02 | PFIZER INC. | $13 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2024 | |
| 2024-09-05 | Edwards Lifesciences Corporation | $20 | Food and Beverage | In-kind items and services | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) Device, Transcatheter Heart Valves | 2024 | |
| 2024-08-21 | Aimmune Therapeutics, Inc. | $13 | Food and Beverage | In-kind items and services | ZENPEP Drug, ENDOCRINE PANCREATIC INSUFFICIENCY | 2024 | |
| 2024-07-31 | Novartis Pharmaceuticals Corporation | $15 | Food and Beverage | In-kind items and services | ENTRESTO Drug, Cardiology/Vascular Diseases | 2024 | |
| 2024-07-17 | Gilead Sciences, Inc. | $14 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-06-26 | E.R. Squibb & Sons, L.L.C. | $19 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2024 | |
| 2024-05-22 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | DALVANCE Drug, ANTI-INFECTIVE | 2024 | |
| 2024-05-15 | Aimmune Therapeutics, Inc. | $15 | Food and Beverage | In-kind items and services | ZENPEP Drug, ENDOCRINE PANCREATIC INSUFFICIENCY | 2024 | |
| 2024-04-04 | AstraZeneca Pharmaceuticals LP | $15 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-04-02 | Amgen Inc. | $17 | Food and Beverage | In-kind items and services | Repatha Biological, Cardiology | 2024 | |
| 2024-03-14 | Medtronic, Inc. | $16 | Food and Beverage | In-kind items and services | INTELLIS ADAPTIVESTIM Device, Spinal Cord Neurostimulation | 2024 | |
| 2023-11-29 | E.R. Squibb & Sons, L.L.C. | $14 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2023 | |
| 2023-11-22 | PFIZER INC. | $13 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2023 | |
| 2023-10-25 | Horizon Therapeutics plc | $14 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-05-31 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-04-18 | Amgen Inc. | $16 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2023 | |
| 2023-03-29 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | BREZTRI Drug, Respiratory | 2023 | |
| 2023-02-21 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-02-08 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | BREZTRI Drug, Respiratory | 2023 | |
| 2023-01-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | $27 | Food and Beverage | In-kind items and services | SPIRIVA RESPIMAT Drug, RESPIRATORY | 2023 | |
| 2022-12-14 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | BREZTRI Drug, Respiratory | 2022 | |
| 2022-11-02 | AstraZeneca Pharmaceuticals LP | $12 | Food and Beverage | In-kind items and services | BREZTRI Drug, Respiratory | 2022 | |
| 2022-10-12 | Kowa Pharmaceuticals America, Inc. | $12 | Food and Beverage | Cash or cash equivalent | Seglentis Drug, Pain Management | 2022 | |
| 2022-09-14 | Janssen Pharmaceuticals, Inc | $18 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2022 | |
| 2022-08-25 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | BREZTRI Drug, Respiratory | 2022 | |
| 2022-04-05 | Amgen Inc. | $12 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2022 | |
| 2022-03-02 | E.R. Squibb & Sons, L.L.C. | $14 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2022 | |
| 2022-01-25 | Amgen Inc. | $11 | Food and Beverage | In-kind items and services | Aimovig Biological, Neuroscience | 2022 | |
| 2021-12-08 | Eisai Inc. | $19 | Food and Beverage | Cash or cash equivalent | 2021 | ||
| 2021-11-03 | Amgen Inc. | $23 | Food and Beverage | In-kind items and services | Otezla Drug, Inflammation | 2021 | |
| 2021-10-19 | MorphoSys, US Inc. | $13 | Food and Beverage (15 payments) | In-kind items and services | MONJUVI Drug, Oncology | 2021 | |
| 2021-09-30 | Novo Nordisk Inc | $11 | Food and Beverage | In-kind items and services | RYBELSUS Drug, Diabetes | 2021 | |
| 2021-09-29 | PFIZER INC. | $12 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2021 | |
| 2021-09-02 | Advanced Respiratory, Inc | $24 | Food and Beverage | In-kind items and services | Life 2000 Ventilation System Device, Airway Clearance Device | 2021 | |
| 2021-08-10 | Kowa Pharmaceuticals America, Inc. | $11 | Food and Beverage | Cash or cash equivalent | Livalo Drug, Cardiovascular | 2021 | |
| 2021-07-14 | PFIZER INC. | $13 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2021 | |
| 2021-06-22 | JAZZ PHARMACEUTICALS INC. | $11 | Food and Beverage | In-kind items and services | SUNOSI Drug, NEUROLOGY | 2021 | |
| 2021-06-15 | Kowa Pharmaceuticals America, Inc. | $12 | Food and Beverage | Cash or cash equivalent | Livalo Drug, Cardiovascular | 2021 | |
| 2021-05-18 | Takeda Pharmaceuticals U.S.A., Inc. | $12 | Food and Beverage | In-kind items and services | GLASSIA Biological, IMMUNOLOGY | 2021 | |
| 2021-04-29 | Roche Diagnostics Corporation | $17 | Food and Beverage | In-kind items and services | cobas 6800 System Device, Molecular Diagnostics | 2021 | |
| 2021-04-27 | Eisai Inc. | $11 | Food and Beverage | Cash or cash equivalent | Dayvigo Drug, Neurology | 2021 | |
| 2021-04-20 | NESTLE HEALTHCARE NUTRITION INC. | $12 | Food and Beverage | In-kind items and services | ZENPEP Drug, ENDOCRINE PANCREATIC INSUFFICIENCY | 2021 | |
| 2021-03-25 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-03-17 | Xeris Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | KEVEYIS Drug, CARBONIC ANHYDRASE INHIBITOR | 2021 | |
| 2021-02-03 | Biohaven Pharmaceuticals, Inc. | $14 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2021 | |
| 2021-01-28 | Eisai Inc. | $17 | Food and Beverage | Cash or cash equivalent | Dayvigo Drug, Neurology | 2021 | |
| 2020-12-22 | PFIZER INC. | $12 | Food and Beverage | In-kind items and services | CHANTIX Drug, NEUROSCIENCE;TOBACCO DEPENDENCE | 2020 | |
| 2020-11-24 | Allergan, Inc. | $12 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2019-11-22 | Circassia Inc. | $15 | Food and Beverage | In-kind items and services | DUAKLIR PRESSAIR Drug, PULMONARYRESPIRATORY DISEASES | 2019 | |
| 2019-11-19 | Kowa Pharmaceuticals America, Inc. | $11 | Food and Beverage | Cash or cash equivalent | Livalo Drug, Cardiovascular | 2019 | |
| 2019-10-21 | DERMIRA, INC. | $12 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-10-16 | PFIZER INC. | $10 | Food and Beverage | In-kind items and services | CHANTIX Drug, NEUROSCIENCE;TOBACCO DEPENDENCE | 2019 | |
| 2019-10-10 | Roche Diagnostics Corporation | $22 | Food and Beverage | In-kind items and services | MD cobas Instruments and Reagents Device, Molecular Diagnostics | 2019 | |
| 2019-07-09 | PFIZER INC. | $11 | Food and Beverage | In-kind items and services | CHANTIX Drug, NEUROSCIENCE;TOBACCO DEPENDENCE | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Sandstone, MN, county Pine County, MN, state Minnesota; placed by its city name.
| Measure | Place (city or town) Sandstone, MN | County Pine County, MN | State Minnesota |
|---|---|---|---|
| Population B01003 | 2,482 | 29,640 | 5,739,445 |
| Population, 2020 census P1 | 2,462 | 28,876 | 5,706,494 |
| Median age B01002 | 39.9 | 45.9 | 38.8 |
| Under 18 B01001 | 11.6% | 19.1% | 22.9% |
| 65 and over B01001 | 11.6% | 22.5% | 17.3% |
| Households B11001 | 684 | 12,323 | 2,307,955 |
| Foreign born B05002 | 8.5% | 1.7% | 8.7% |
| Median household income B19013 | $51,875 | $71,146 | $89,062 |
| Median family income B19113 | $62,083 | $86,094 | $113,993 |
| Per capita income B19301 | $18,414 | $35,805 | $48,237 |
| Poverty rate B17001 | 25.2% | 11.1% | 9.3% |
| Unemployment rate B23025 | 7.4% | 5.6% | 4.1% |
| Civilian labor force B23025 | 634 | 14,038 | 3,119,042 |
| Mean commute (minutes) B08013 | 24.2 | 32.1 | 22.7 |
| Bachelor's degree or higher B15003 | 12.3% | 17.4% | 39.4% |
| Housing units B25001 | 724 | 17,284 | 2,545,030 |
| Owner-occupied B25003 | 52.9% | 81.6% | 72.2% |
| Renters B25003 | 47.1% | 18.4% | 27.8% |
| Median home value B25077 | $166,300 | $239,300 | $329,300 |
| Median gross rent B25064 | $1,015 | $877 | $1,280 |
| White, not Hispanic B03002 | 69.3% | 87.2% | 75.9% |
| Black B03002 | 9.1% | 2.3% | 6.9% |
| Hispanic or Latino B03002 | 11.9% | 2.8% | 6.4% |
| Asian B03002 | 1.5% | 1.1% | 5.1% |
| American Indian and Alaska Native B03002 | 4.8% | 2.2% | 0.7% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Sandstone, MN.
Comments